Publications-ELK Biotechnology CO.,Ltd.

Technical

IF：18.5 Date：2025-05-13

ADVANCED FUNCTIONAL MATERIALS

Inhibiting Chemotherapy Immune Tolerance and Reversing Tumor Microenvironment by Macrophage-Targeted Nanohybrid Systems for Enhancing Tumor Chemo-Immunotherapy

Products： ELK1387
IF：2.1 Date：2025-05-13

FUNDAMENTAL & CLINICAL PHARMACOLOGY

JAK/STAT inhibitors mitigate sepsis-associated cerebral and cognitive injury

Products： ELK1387
IF：2.7 Date：2025-05-13

Journal of Cancer Research and Clinical Oncology

Investigating the role of HMGA2 plasma level as a diagnostic marker in bladder urothelial carcinoma patients

Products： ELK3464
IF：2.8 Date：2025-05-13

Medical Oncology

Dual facets of MSC-derived small EVs: regulatory insights into antitumor mechanisms in pancreatic ductal adenocarcinoma

Products： ELK1142、 ELK1156、 ELK1190、 ELK1270、 ELK1951

< Page of 308 >